U.S. Biotech Stock News

The Carlyle Group Inc. recently reported its third quarter 2025 earnings, revealing quarterly revenue of US$332.7 million and net income of US$0.9 million, both down sharply from the same period in 2024; for the nine months ended September 30, revenue was US$2.88 billion and net income was US$450.6 million. Despite the drop in earnings, Carlyle declared a quarterly dividend of US$0.35 per share, signaling its ongoing commitment to shareholder returns during a period of weaker financial...

Earlier this month, Viatris Inc. announced an increase in its full-year 2025 revenue guidance to a midpoint of US$14.1 billion, up from its previous midpoint of US$13.75 billion, while also outlining continued M&A ambitions and affirming a quarterly dividend of US$0.12 per share. This more optimistic outlook comes despite reporting a third-quarter net loss and declining revenue for the nine months ended September 30, 2025, suggesting management anticipates improvements ahead. We'll explore...

The Walt Disney Company recently reported its fourth-quarter and full-year results, highlighting nearly flat quarterly revenue of US$22.46 billion but a major increase in net income to US$1.31 billion from US$460 million a year prior. This profit surge reflects ongoing cost management, successful streaming initiatives, and new integrations such as Hulu into Disney+, even as Disney faces operational pressures in theme parks and legal challenges in international markets. We'll examine how...

Curious if Grindr stock is undervalued right now, or just catching your attention for the wrong reasons? You’re not alone. Investors want to know if there is real opportunity hiding behind the headlines. After a rough start to the year, Grindr shares are up 5.8% in the past week and 12.9% over the last month. However, the stock is still down almost 20% year-to-date. Much of the recent price movement has been driven by news of strategic expansions and fresh partnerships within the digital...

Dillard's, Inc. has announced its third quarter fiscal 2025 earnings, reporting US$1.47 billion in sales and US$129.8 million in net income, both showing year-over-year growth compared to the prior year period. A key highlight is the company’s improved basic and diluted earnings per share from continuing operations, which both rose to US$8.31 from US$7.73 a year earlier, reflecting strong operational performance. We'll explore how the continued improvement in earnings per share shapes...

Moderna (MRNA) shares were in focus after the company posted third quarter results that topped analyst expectations for both revenue and earnings per share. Despite ongoing revenue declines, the updated guidance and operational adjustments sparked renewed investor interest. See our latest analysis for Moderna. After these results, Moderna’s share price rallied more than 13% over the past week, with much of this momentum coming right after its Q3 earnings beat, even as the company narrowed and...

Hecla Mining Company recently reported robust third-quarter 2025 results, with silver production rising to 4,590,276 ounces and gold output reaching 40,654 ounces, both up compared to the prior year, and sales climbing to US$409.54 million. Alongside higher dividends declared and tightened full-year production guidance, the company’s stronger financial management and increased operational output highlight improved business resilience and ongoing confidence in sector demand trends. We’ll now...

In the past week, Evergy, Inc. announced a 4% dividend increase and reported third quarter results showing steady revenue and earnings, while also highlighting progress on major data center agreements totaling about US$200 million in commitments. This combination of higher dividends and expanding partnerships with large-scale data center customers points to a growing focus on long-term demand growth and shareholder returns. We'll explore how Evergy's recent data center customer agreements...

In November 2025, Northwest Natural Holding Company updated its 2025 earnings guidance, anticipating results above the midpoint of its revised GAAP EPS range of US$2.59 to US$2.79, and reported third-quarter sales of US$164.73 million with a net loss of US$29.89 million. The company also highlighted year-to-date sales growth to US$895.21 million and net income of US$55.53 million, marking improvements over the prior year. An interesting insight is that despite a quarterly loss, Northwest...

Penumbra, Inc. recently reported third quarter results with sales reaching US$354.69 million and net income rising to US$45.85 million, alongside raising its 2025 revenue guidance and publishing strong clinical trial data for its vacuum thrombectomy technology. Importantly, new evidence from the STORM-PE trial underscores the clinical potential of Penumbra's CAVT procedure, showing superior patient outcomes in pulmonary embolism treatment compared to standard care. We'll examine how...

Arthur J. Gallagher (AJG) recently posted its third quarter results. The company reported revenue gains driven by recent acquisitions, even as quarterly net income and earnings per share slipped compared to last year. See our latest analysis for Arthur J. Gallagher. Arthur J. Gallagher’s share price has faced some pressure lately, with a 1-month return of -15.48% and a 1-year total shareholder return of -12.19%. Even so, the company’s ongoing string of acquisitions and steady revenue growth...

If you have ever wondered whether Titan America is truly a bargain or just another stock to watch, you are in the right place for some answers. The share price has jumped 5.4% over the last week and sits up 4.0% for the past month, but it is still down 6.0% year-to-date, hinting at both fresh optimism and lingering uncertainty. Recent news has spotlighted industry shifts and policy discussions that relate directly to Titan America’s core business, fueling speculation on its future direction...

Avidity Biosciences (RNA) shares have climbed nearly 45% over the past month, defying the broader biotech trend. The stock’s recent momentum has caught the attention of investors looking for meaningful growth stories in the sector. See our latest analysis for Avidity Biosciences. Building on its recent surge, Avidity Biosciences has not only posted a remarkable 44.7% one-month share price return, but is also up an impressive 127% for the year to date. Momentum has picked up noticeably, and...

Srini Gopalan, President and CEO of T-Mobile US, recently purchased 9,800 shares of T-Mobile stock, reflecting leadership's confidence amid several major company initiatives including technological upgrades, expanded satellite emergency services, a new partnership with CNN, and the launch of a T-Mobile-branded credit card. This insider purchase, coupled with ongoing innovations in 5G and emergency communications, highlights T-Mobile's efforts to reinforce its position as a technology leader...

Coterra Energy (CTRA) just increased its production guidance for 2025, citing strong natural gas demand and healthy business momentum. The company also delivered better-than-expected revenue, reaffirmed its quarterly dividend, and resumed its share repurchase program. See our latest analysis for Coterra Energy. Following the upbeat guidance and operational results, Coterra Energy’s 30-day share price return of 11.3% stands out against a tougher start to the year. Its 1-year total shareholder...

Atlas Energy Solutions reported a net loss for the quarter and announced a suspension of its dividend, putting the company’s financial health in the spotlight. Investors are watching closely as these challenges unfold. See our latest analysis for Atlas Energy Solutions. The string of setbacks for Atlas Energy Solutions, including reporting a sizable quarterly loss and suspending its dividend, has clearly weighed on investor confidence and momentum. The company’s 10% dip in share price just...

In November 2025, The Wendy’s Company’s subsidiaries commenced marketing a US$400 million offering of new fixed rate senior secured notes to refinance existing debt, alongside reporting mixed third-quarter financial results with slightly lower net income and higher impairment charges. This combination of capital restructuring and confirmed weak sales expectations for 2025 highlights the company’s focus on managing financial obligations amid ongoing profitability challenges. We’ll now examine...

N-able, Inc. recently reported third-quarter earnings, revealing a year-over-year decline in net income to US$1.38 million and a net loss of US$9.8 million for the first nine months of 2025, compared to net income during the same periods in the prior year. The company also issued updated fourth-quarter and full-year 2025 revenue guidance, projecting around 9% growth, while analyst ratings remained generally neutral and insider selling increased. We'll examine how the weaker profitability and...

West Pharmaceutical Services (WST) shares have edged lower over the past week, dipping about 3%. Investors are watching closely to see if recent trends in pharma packaging and component demand could signal a shift in sentiment for the company. See our latest analysis for West Pharmaceutical Services. While West Pharmaceutical Services has seen its share price drop 16.6% year-to-date, a recent bounce over the last month hints at shifting momentum. The stock’s 1-year total shareholder return...

On November 5, 2025, Sabra Health Care REIT announced its third-quarter earnings, updated full-year earnings guidance, reaffirmed a US$0.30 quarterly dividend payout, and disclosed a US$2.57 million real estate impairment. While quarterly net income and sales declined year-on-year, revenue grew and full-year net income guidance was increased, signaling resilience alongside the dividend commitment. We’ll now examine how Sabra’s updated earnings guidance and continued dividend payments shape...

Warner Bros. Discovery (WBD) stock has drawn attention recently due to its strong run over the past month, climbing nearly 25%. Investors are now looking for clues about what could drive the next phase of its share price performance. See our latest analysis for Warner Bros. Discovery. This recent surge has more than doubled Warner Bros. Discovery’s share price year-to-date, with a 108% gain that is mirrored by a 128% total shareholder return over the last twelve months. Momentum has clearly...

In November 2025, GE Vernova began operations at the Jafurah Cogeneration ISPP in Saudi Arabia and announced it would acquire the remaining 50% ownership of Prolec GE, highlighting its global expansion and asset control. Industry attention has also turned to GE Vernova’s critical role in supplying infrastructure for nuclear and gas power, reinforced by ongoing supply constraints and demand from sectors such as data centers and artificial intelligence. These milestones underscore GE Vernova’s...

Salesforce (CRM) shares have seen slight movement recently, leaving investors considering what may influence the stock in the coming weeks. With the price hovering around $240, the market response suggests a wait-and-see approach. See our latest analysis for Salesforce. Looking at the longer-term picture, Salesforce’s share price return over the past year is down more than 27 percent. The recent lackluster movement hints at investor caution about near-term growth or shifting sentiment in the...

Thinking about jumping into Coinbase Global stock or just trying to figure out if it offers real value? You are not alone; many investors are asking the same questions right now. Despite a solid 18.2% gain so far this year and an eye-catching 522.6% return over the last three years, shares have slipped by 4.8% in the past week and 14.8% over the last month. This reveals just how quickly market sentiment can shift. Recent headlines have focused on mounting regulatory discussions and the...